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Abstract
Purpose To evaluate the outcomes of the Femto-LASIK
method in the treatment of refractive errors following pene-
trating keratoplasty (PK) at the Persian Eye Clinic, Isfahan,
Iran
Methods In a prospective, non-comparative case series, 34
consecutive symptomatic eyes of 34 patients after corneal
graft, were operated on. Tissue-saving (TS) Femto-LASIK
(n =16), and Zyoptix Personalized Treatment Advanced
(PTA) Femto-LASIK (n =18) were performed using the
Bausch & Lomb Technolas 217z excimer laser and Zyoptic
algorithm. Uncorrected visual acuity (UCVA), best-corrected
visual acuity (BCVA), manifest refraction, contrast sensitivity,
and HOAs were evaluated preoperatively and 12 months after
enhancement treatment.
Results At 12 months, the mean preoperative myopic spher-
ical equivalent refraction (SE) decreased from −6.50±2.8 D to
−1.6±1.8 D, and mean hyperopic SE from +3.2±2.20 D to
0.37±1.2 D. The safety index was 1.42 (1.2 in the TS group
and 1.5 in the PTA group). In the TS group, 100 % of eyes
achieved 20/80 or better UCVA and 50 %, 20/40 or better and
in the PTA group, 100 % of eyes achieved 20/80 or better
UCVA and 77.7 %, 20/40 or better. The efficacy index was
1.08 (0.9 in TS group and 1.21 in the PTA group). Patients
obtained statistically significant lower values of root mean
square (RMS) of HOAs with spherical aberrations (p <0.05).
Conclusions Femto-LASIK method with Zyoptic programs
after PK was safe, effective, and predictable for correction of
spherical and cylindrical components of the refractive error.
Keywords Corneal graft . Tissue saving . Personalized
Treatment Advanced . Femto-LASIK
Introduction
Visual rehabilitation after penetrating keratoplasty remains
challenging. The presence of astigmatism and other ametropia
is a major hurdle in the visual rehabilitation of patients who
have undergone penetrating keratoplasty. They often cannot
be corrected by spectacles due to aniseikonia, therefore surgi-
cal approaches are of interest. Surgical methods to improve
astigmatism following penetrating keratoplasty (PK) include
continuous suture adjustment [1], selective suture removal [2],
compression sutures [3], wedge resection [4, 5], transverse
keratotomies, augmentation sutures [6, 7], and more recently
the use of excimer laser photorefractive surgery. Laser in situ
keratomileusis (LASIK) is a widely accepted method for
treating a great range of refractive errors and has been suc-
cessfully used in treating patients requiring refractive surgery
after PK as well [8–13].
Laser instruments differ in delivery platform, software de-
sign, ablation profile, and treatment zones and treat varying
types of higher-order aberration (HOA), which could have a
measurable impact on visual performance [14]. Femtosecond
thin-flap LASIK or Femto-LASIK has been shown to safely and
effectively reduce postoperative refractive error (in particular
the spherical component) in patients who have previously un-
dergone PK [15]. The purpose of this prospective study was to
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evaluate the 12-month postoperative visual outcomes of Femto-
LASIK method with the Zyoptic algorithm using a scanning-
spot 217z excimer laser (Bausch&Lomb) for residual refractive
error after penetrating keratoplasty.
Patients and methods
Patients
Thirty-seven eyes with residual astigmatism and ametropia
following penetrating keratoplasty that could not be adequately
corrected by contact lenses or spectacles were assessed for
LASIK and underwent Femto-LASIKwith tissue-savingmeth-
od or Femto-LASIK with Personalized Treatment Advanced
(PTA) betweenMarch and December 2011. The study protocol
was approved by the ethical committee of Isfahan University of
Medical Sciences. Three patients who failed to attend all the
visits and undergo all the clinical examinations required were
excluded from this study. Out of the 34 patients studied, 12
were male and 22 were female. Twenty-three grafts had been
performed for keratoconus, two for Fuchs endothelial dystro-
phy, five for posttraumatic scares, and four for pseudophakic
bullous keratopathy.
The average age of the patients at the time of LASIK was
32 years with a range of 21–49 years. Corneal graft sizes
ranged from 7.0 to 8.5 mm (mean, 8 mm). The mean interval
between penetrating keratoplasty and LASIK was 8 years and
11 months, with a range of 1 year and 11 months to 23 years
and 2 months. All eyes had had the graft sutures removed a
minimum of 10 months before LASIK.
A full ophthalmological examination was performed on all
patients prior to surgery, including uncorrected visual acuity
(UCVA) and best-corrected visual acuity (BCVA) (were tested
with the Snellen chart), manifest and cycloplegic refraction, slit-
lamp examination with fundus evaluation, corneal topography
(Orbscan II z, version 3.10.31, Bausch & Lomb), wavefront
assessment Zywave (Wavefront Analyzer,Wavelight), ultrasonic
pachymetry. Informed consent was obtained from all patients
after a thorough explanation of the two procedures and their
potential benefits and risks.
Careful slit-lamp microscopy was performed throughout
the 360° of the graft host junction to ensure that there was no
posterior graft-host junction gape, anterior-posterior displace-
ment, or unevenwound healing before inclusion for treatment.
The corneal radiuses of curvature were measured by the
Orbscan II topographer, which operates on the principle that
light rays. Three Orbscan II maps were taken, and the one with
the least eye movements was used. The maximummovements
considered acceptable were 200μm. Exclusion criteria includ-
ed heavily vascularized corneae, simulated keratometry read-
ings below 38 diopters (D) or greater than 55 D, anterior
posterior misalignment of the graft–host junction of greater
than an estimated 10 %, and internal gaping of the graft host
junction of greater than 20 % of corneal thickness. The treat-
ment goal was primarily to reduce the refractive error to a
great extent and not necessarily emmetropia, since the preop-
erative refractive disorders were quite high.
Surgery
Sixteen patients underwent Femto-LASIK treatment with
tissue-saving method (TS group) and 18 patients underwent
Femto-LASIK with Personalized Treatment Advanced (PTA
group).
The Ziemer Femto LDV femtosecond laser was used to create
the corneal flap for all the eyes. Selected flap diameter was 9 mm
with superior hinge position, and flap thicknesswas 100μm in all
eyes. The decision of whether to perform TS or PTA technique
was made based on preoperative aberrometry findings. Zywave
aberrometry was tried in all patients. If a qualified aberrometry
could be obtained, the patient was candidate for the PTA tech-
nique; otherwise the patient underwent the TS technique. The
optical zone was set between 5.5 and 6 mm, according to
estimated residual bed. The excimer laser platform used for the
two groups was the Bausch & Lomb Technolas 217z.
All patients were operated on by a single surgeon. A residual
stromal bed of 280 μm or more was left in all eyes. After
surgery, all patients were given dexamethasone (0.1 %) every
2 h on the first day and four times daily for a week, ciproflox-
acin every 4 h on the first day and four times daily for a week,
and artificial tear artificial tears for 3 months. Postoperatively,
the patients were seen at 1 day, 1 week, 1, 3, 6, and 12 months.
Data analysis
The main parameters evaluated in this study included visual
parameters: manifest refractive spherical equivalent refraction
(MRSE), astigmatism, UCVA, BCVA, and higher-order
aberrations (HOAs). All parameters are expressed as means
and standard deviation and were analyzed using a t test with
software program SPSS (version 15.5, SPSS Inc., Chicago,
IL, USA). A p value less than 0.05was considered statistically
significant.
Results
The mean myopic spherical equivalent preoperatively was
−6.5±2.8 (range, −11.38 D to −0.38 D) and mean hyperopic
spherical equivalent preoperatively was 3.2±2.2 (range, 0.5–
6.63 D). The mean preoperative astigmatism was −4.88±2.4
(−9.00 to 0.00 D). In 34 eyes the preoperative uncorrected
visual acuity (UCVA) was 1.01±0.34. Preoperative best spec-
tacle corrected visual acuity (BCVA) ranged between 20/200
and 20/20. Improvements in meanUCVA, BCVA, and higher-
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order aberrations occurred in the tissue-saving LASIK and
PTA LASIK groups at follow-up intervals (Tables 1 and 2).
The ablation depth per diopter of defocus equivalent was
11.9±5.2 m/D in the TS group and 19.1±10.1 m/D in the PTA
group.
Intraoperative and postoperative complications such as
wound dehiscence, buttonhole, partial flap, and graft rejection
did not develop in this series of eyes.
Tissue-saving Femto-LASIK group
In the tissue-saving Femto-LASIK group (16 eyes), mean
UCVA improved from 1.1±0.25 logMAR (range, 0.5–1.3
logMAR) to 0.36±0.19 logMAR (range, 0.00–0.7 logMAR)
at 12months, whereas meanBCVA improved from 0.32±0.24
logMAR (range, 0.0 to 1.00 logMAR) to 0.19±0.13 logMAR
(range, 0.00 to 0.5 logMAR) at 12 months (Table 1). A
statistically significant increase was noted in postoperative
UCVA and BCVA at 1 and 12 months compared to the
preoperative (p =0.008, and p =0.008, respectively). No eyes
lost any lines of BCVA, six maintained their BCVA, four eyes
gained one line, and others gained three or more lines. The
mean gain at 12 months was 4.9 lines of UCVA and 1.9 lines
of BCVA (Figs. 1 and 2). Refractive error for the TS Femto-
LASIK group improved from sphere −3.39±4.1 diopters (D)
(range, −8.75 to 6.25 D) to −0.51+/−1.9 D (range, −5.00 to +
4.00 D) (was significant p =0.002), and from cylinder −6.06±
2.2 D (range, −9.00 to −1.75 D) preoperatively to cylinder
−2.37±1.4 D (range, −5.75 to 0.00 D) postoperatively at
12 months, with a significant difference for 1 and 12 months
(p =0.00006 and p =.04, respectively (Table 1; Fig. 3). The
axis between pre- and postoperative cylinder was within ±10°.
Attempted versus achieved spherical equivalent (SEQ) refrac-
tion for the TS Femto-LASIK group can be seen in Fig. 4a
(R2=0.86). Higher-order aberrations after TS Femto-LASIK
decreased both with a 5- and 6-mm pupil, but this decrease
was not statistically significant (Table 2).
PTA Femto-LASIK group
In the PTA Femto-LASIK group (18 eyes), mean UCVA
improved from 0.88±0.37 logMAR (range, 0.25 to
1.3 logMAR) to 0.17±0.18 logMAR (range, 0.00 to 0.5
logMAR) at 12 months, and mean BCVA improved from
0.25±0.12 logMAR (range, 0.05 to 0.5 logMAR) to 0.05±
0.12 logMAR (range, −0.1 to 0.25) at 12 months. A statistically
significant increase was noted in UCVA and BCVA at
12 months compared to the preoperative (p=.0001, p=.002)
(Table 2). No eyes lost any lines of BCVA, five maintained their
BCVA, and 13 eyes gained one or higher lines of BCVA. The
mean gain at 12 months was 6.05 lines of UCVA and 3.2 line of
BCVA (Figs. 1 and 2). In the PTA Femto-LASIK group,
refractive error improved from sphere −2.02± 4.5 D (range,
−9.00 to 8.25 D) to 0.002±1.81 D (range, −4.25 to 2.25 D) at
12 months (p =0.07), and from cylinder −3.83±2.09 D (range,
−6.75 to 0.00 D) preoperatively to −1.9±1.21 D (range, −4.5 to
−0.25 D), reaching significance at 12 months postoperatively
(p=.0003) (Table 2). The axis between pre- and postoperative
cylinder was within ±1°. Attempted versus achieved spherical
equivalent (SEQ) refraction for PTA Femto-LASIK group can
be seen in Fig. 4b (R2=0.80). Higher-order aberrations with and
without spherical aberration decreased greatly and significantly
after PTA Femto-LASIK with a 5- and 6-mm pupil (Table 2).
Discussion
High refractive errors are a frequent finding after PK [16–18]
and reduce the patient’s perception of success following cor-
neal transplantation. High anisometropia impairs visual reha-
bilitation and compromises the patient’s ability to return to
normal binocular functions.
LASIK has been widely used since its inclusion in the
clinical routine in the early 1990s to treat a great range of
refractive disorders. By performing laser ablation in the
Table 1 Visual parameters in the
Femto-LASIK ablation group
before treatment and 12 months
after treatment (mean ± SD)
BCVA best-corrected visual
acuity, UCVA uncorrected visual
acuity, RMS root mean square
Parameters Pre-operative Post-operative p value
Cylinder (D) −4.88±2.4 −2.1±1.3 0.00005
Spherical equivalent (D) Myopic −6.5±2.8 −1.6±1.8 0.0003
Hyperopic 3.2±2.2 0.37±1.2 0.03
BCVA (-LogMAR) 0.28±0.19 0.12±0.14 0.0001
UCVA (LogMAR) 1.01±0.34 0.25±0.2 0.0001
RMS higher-order 5 mm 1.29±0.5 1.08±0.45 0.02
RMS HAw/o z400 5 mm 1.16±1.7 1.03±0.44 0.18
RMS total 5 mm 6.7±3.2 2.63±1.3 0.000
RMS higher-order 6 mm 2.45±1.2 1.97±0.84 0.33
RMS HAw/o z400 6 mm 2.18±1.06 1.82±0.82 0.18
RMS total 6 mm 10.58±4.9 4.4±2.1 0.000
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corneal stroma, postoperative wound healing reaction is very
mild and the risk of scarring and haze formation is very low
[19, 20].
LASIK combines a high patient convenience due to the
lack of postoperative complaints and fast visual recovery with
predictable, precise, and stable results. In addition, the rate of
serious complications is very low [21, 22] due to the evolution
of the hardware used and the standardized procedure, which
makes LASIK the most frequently used mode of treatment in
corneal refractive surgery.
Both microkeratome and Femto-LASIK have been shown
to be effective in the correction of post-PK ametropia, partic-
ularly the spherical component [15]. To our knowledge, this is
the first paper on the application of Femto-LASIK for
ametropia correction in post-PK patients using the tissue-
saving treatment or APT. This series has demonstrated that
Femto-LASIK after a corneal graft can be a safe and effective
procedure. Our mean reduction in spherical equivalent from
−5.1 D to −1.32 D is comparable with the largest previously
reported series where the spherical equivalent in those reaching
12 months’ follow-up decreased from −10.06 D to −4.13 D
[15, 23]. However, the preoperative refractive error is nearly
twice as much in the TS group, which introduces a bias.
Our results show excellent safety indices (BCVA post/
BCVA pre) of 1.42 in all patients and 1.2 and 1.5 in the TS
Femto-LASIK and PTA Femto-LASIK groups, respectively.
In addition, most eyes maintained their BCVA and some
gained multiple lines of BCVA. Moreover, in the TS Femto-
LASIK group, ten eyes (62.5 %) gained 1–6 lines of BCVA
and in the PTA Femto-LASIK group 13 eyes (72%) gained 1–
6 lines of BCVA. Although two eyes in the PTA group
Table 2 Tissue-saving Femto-LASIK and PTA Femto-LASIK outcomes
Parameters TS group PTA group
Surgery type Pre-op Post-op p value Pre-op Post-op p value
Eyes per group, n 16 16 18 18
Mean SE (D) −6.4+/−3.8 −1.7+/−1.4 0.0000 −3.94+/−4.6 −0.98+/−2.2 0.003
Mean astigmatism (D) −6.06+/−2.2 −2.37+/−1.4 0.0000 −3.83+/−2.09 −1.9+/−1.2 0.0000
BCVA (LogMAR) 0.32±0.24 0.19±0.13 0.04 0.25±0.12 0.05±0.12 0.004
UCVA (LogMAR) 1.1±0.25 0.36±0.19 0.00 0.88±0.37 0.17±0.18 0.000
RMS higher-order 5 mm 1.38±0.68 1.34±0.39 0.81 1.2±0.26 0.85±0.37 0.001
RMS HAw/o z400 5 mm 1.21±0.7 1.27±0.41 0.64 1.1±0.3 0.81±0.36 0.004
RMS total 5 mm 7.79±3.07 3.48±1.06 0.000 5.8±3.1 1.87±1.09 0.000
RMS higher-order 6 mm 2.49±1.3 2.4±0.77 0.85 2.23±0.52 1.5±0.67 0.004
RMS HAw/o z400 6 mm 2.1±1.3 2.22±0.8 0.82 2.09±0.56 1.45±0.66 0.009
RMS total 6 mm 12.91±4.9 5.59±1.6 0.0000 8.38±4.06 3.3±1.9 0.001
TS tissue-saving, PTA Personalized Treatment Advanced, SE sphere equivalent, BCVA best-corrected visual acuity, UCVA uncorrected visual acuity,
LASIK laser-assisted in-situ keratomileusis
Fig. 1 Patients’ UCVA 12 months after LASIK
Fig. 2 Stability of spherical equivalent refraction (SEQ) over time after
tissue-saving Femto-LASIK and PTA Femto-LASIK
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achieved a BCVA of 20/12, no super vision (visual acuity 20/
10) was measured.
These findings are accordant with other studies [24–30],
which have shown LASIK as an effective mode of treatment
for refractive errors following PK.
Table 3 summarizes the results from studies that evaluated
the efficacy and safety of LASIK for treatment of residual
myopia or hyperopia in PKP eyes. Compared with these other
studies, higher percentages of eyes in the present Femto-
LASIK patients achieved UCVA of ≥_20/20 and ≥20/40.
Barequet et al. [15] performed Femto-LASIK in nine patients
with ametropia after penetrating keratoplasty and showed a sig-
nificant decrease in sphere and cylinder and a gain of ≥2 lines in
BCVA in 33 % patients. Our study shows an improvement in
UCVA after surgery for all eyes, with 100 % of eyes having
UCVAs of 20/200 or better at 12 months (Fig. 1). Efficacy
indexes were good in all patients; 1.21 in the TS Femto-LASIK
group and 0.9 in the PTA Femto-LASIK group. Predictability
was also good; in PTAFemto-LASIK group 83.3% of eyeswere
within the ±1 D range in SE and in the TS Femto-LASIK group
68.75 %. The stability index at the 12-month period was excel-
lent for all patients (0.08-D change of SE) (Fig. 3).
Preoperative SE in the TS Femto-LASIK group was −2.00
Dmore myopic than in the PTA Femto-LASIK group, and the
measured ablation depth per diopter of defocus equivalent was
40 % less in the TS group. In our opinion, this tissue-saving
effect of the Zyoptic treatment is a major advantage of this
ablation technique. The resolution of anisometropia was the
goal of LASIK in most patients in this study.
Many factors such as the size, curvature, and thickness of
the corneal transplant, the underlying disease for the PK,
preoperative refraction, the trephination technique, the type
of suture, size and alignment of the corneal flap, whether the
complete transplant is included in the lamellar flap or not,
location of the hinge, the kind of microkeratome, and the
settings used (advance rate, vacuum), the excimer laser and
the chosen ablation profile as well as healing processes, which
vary among patients affect the refractive outcome of LASIK
after PK. The interactions between these factors are to a great
extent still unknown.
It is reassuring that no eyes lost any lines of BCVA. Corneal
scarring leading to the loss of three or four lines is a serious
complication associated with photoastigmatic keratectomy
[36–38].
A total of 64.7 % of eyes (77.7 % of eyes in PTA Femto-
LASIK group and 50 % of eyes in tissue-saving Femto-
LASIK group) achieved UCVA 20/40 or better at 12 months
or later. The equivalent figure for normal corneas undergoing
toric myopic LASIK is almost 80 % [39]. All eyes in this
study achieved functional unaided acuity measuring 20/100 or
better. We would like to suggest that unaided acuity should be
included as an outcome measure in future reports of the
refractive results of corneal transplantation (Fig. 1). Previous
studies have failed to report uncorrected visual acuity results,
possibly because they are generally not very good.
Fig. 4 Correlation between attempted and achieved spherical equivalent
refraction (SEQ) at 12 months after tissue-saving Femto-LASIK (a) and
PTA Femto-LASIK (b)
Fig. 3 Change in BCVA 12 months after LASIK
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We found this procedure to be relatively free of compli-
cations. Wound healing reaction was mild and no incidence
of graft rejection occurred during the period of review.
Preoperative topical steroid had been suggested to reduce
the incidence of graft rejection, yet this was not a large
problem in this series. These eyes did well with continua-
tion of their baseline steroid dosage with a strong steroid
four times daily for the first month after the LASIK
procedure.
The timing of further refractive surgery may be debated.
The minimum time for LASIK after all sutures had been
removed in this study was 10 months. Our patients had
their penetrating keratoplasty at least 23 months before
LASIK. This report confirms that adequate wound integrity
is present to prevent disruption of the corneal wound
in the treated eyes. Other authors recommend waiting
2–3 years [40].
There were no problems of graft dehiscence on application
of the microkeratome suction ring. Complications noted by
other authors include bleeding into the interface after the
keratome passed, locking of the keratome due to an old nylon
corneal suture [9], and worsening of the refractive error [23].
One theoretical risk is that of inciting a rejection episode. This
has not occurred so far, postoperative steroids probably con-
tribute to ensuring against this.
In our series, we performed the procedure in one step to
allow quicker visual rehabilitation and limit the potential for
complications to one surgery if possible, because the rate of
epithelial ingrowth as a complication is higher in enhancement
procedures.
In this study, a detailed analysis of HOAs showed signifi-
cant improvements in total HOAs and spherical aberrations
12 months after LASIK. These findings have not been report-
ed in previous studies. In particular, we found that HOAs with
spherical aberrations in 5-mm pupils significantly improved
after Femto-LASIK.
Limitations of our study include the small number of
patients, different patient ages, and different preoperative re-
fraction of the patients. As TS LASIK and PTA LASIK have
different indications, we believe a direct comparison in the
same age group and similar refractive errors is not possible. In
addition, a difference in wavefront errors may not be clinically
meaningful, as it might be compensated for by the processing
of the visual system.
The present study showed excellent safety data for ablation
using the Zyoptix system. A great benefit of tissue-saving
Femto-LASIK is the lower ablation depth needed per diopter
of defocus equivalent, which creates a greater safety margin
for the refractive surgeon in the prevention of keratectasia.
Further studies involving groups of patients with different
degrees of myopia and hyperopia are needed to evaluate the
advantages and disadvantages of Femto-LASIK for laser re-
fractive surgery.
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